Triple Therapy Halves Exacerbations In Moderate-To-Severe COPD, Hannover Medical School Study

Published: Oct 08, 2009

Bookmark and Share

EurekAlert! -- Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting ß-agonist (LABA), an inhaled corticosteroid (ICS) and an anti-muscarinic agent, according to researchers in Germany.

Back to news